Our study demonstrated that low expression of CD16 on neutrophils after the therapy was related to decreased frequencies of anti-tumor immune cells, like CD8+T cells and NK cells, suggesting that they may have immunosuppressive activity as MDSCs. Here, CD8A is linked to neoplasm.